BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 17448127)

  • 1. Fasting c-peptide and insulin-like growth factor-binding protein-1 levels help to distinguish childhood type 1 and type 2 diabetes at diagnosis.
    Katz LE; Jawad AF; Ganesh J; Abraham M; Murphy K; Lipman TH
    Pediatr Diabetes; 2007 Apr; 8(2):53-9. PubMed ID: 17448127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinguishing type 1 and type 2 diabetes at diagnosis. What is the problem?
    Rosenbloom AL
    Pediatr Diabetes; 2007 Apr; 8(2):51-2. PubMed ID: 17448126
    [No Abstract]   [Full Text] [Related]  

  • 3. HLA-DRB1*08 allele may help to distinguish between type 1 diabetes mellitus and type 2 diabetes mellitus in Mexican children.
    Rodríguez-Ventura AL; Yamamoto-Furusho JK; Coyote N; Dorantes LM; Ruiz-Morales JA; Vargas-Alarcón G; Granados J
    Pediatr Diabetes; 2007 Feb; 8(1):5-10. PubMed ID: 17341285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [C-peptide as the decisive factor for classification of type 1 diabetes mellitus and type 2 diabetes mellitus].
    Perusicová J; Bárová H; Hill M; Masek Z
    Vnitr Lek; 2002 Jun; 48(6):490-9. PubMed ID: 12132349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postprandial paradoxical IGFBP-1 response in obese patients with Type 2 diabetes.
    Lehtihet M; Efendic S; Brismar K
    Clin Sci (Lond); 2008 Sep; 115(5):167-74. PubMed ID: 18208402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of basal C peptide and its relationship with pancreatic autoantibodies in young adults with type 2 diabetes mellitus.
    Vlad A; Serban V; Sima A; Timar R; Roşu M
    Rom J Intern Med; 2004; 42(2):333-41. PubMed ID: 15529624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inverse changes in fetal insulin-like growth factor (IGF)-1 and IGF binding protein-1 in association with higher birth weight in maternal diabetes.
    Lindsay RS; Westgate JA; Beattie J; Pattison NS; Gamble G; Mildenhall LF; Breier BH; Johnstone FD
    Clin Endocrinol (Oxf); 2007 Mar; 66(3):322-8. PubMed ID: 17302863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of weight at birth and at diagnosis of childhood-onset type 2 diabetes mellitus in Japan.
    Sugihara S; Sasaki N; Amemiya S; Kohno H; Tanaka T; Matsuura N
    Pediatr Diabetes; 2008 Jul; 9(4 Pt 1):285-90. PubMed ID: 18466207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-cell autoantibodies in children with type 2 diabetes mellitus: subgroup or misclassification?
    Reinehr T; Schober E; Wiegand S; Thon A; Holl R;
    Arch Dis Child; 2006 Jun; 91(6):473-7. PubMed ID: 16449253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GADA and islet cell antibodies in Romanian children and adolescents with diabetes mellitus.
    Serban V; Enache A; Vlad A; Sima A; Roşu M; Roşca A; Drăghici C
    Rom J Intern Med; 2004; 42(2):325-32. PubMed ID: 15529623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical presentation and treatment of type 2 diabetes in children.
    Pinhas-Hamiel O; Zeitler P
    Pediatr Diabetes; 2007 Dec; 8 Suppl 9():16-27. PubMed ID: 17991129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic value of humoral and metabolic markers as an evaluation of risk for developing type 1 diabetes].
    Młynarski W; Wyka K; Bodalska-ŁIpińska J; Andrzejewski W; Zmysłowska A; Bodalski J
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2003; 9(1):17-22. PubMed ID: 12831633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diabetes mellitus in children in Lomé (Togo)].
    Gbadoé AD; Barruet R; Lawson-Evi K; Bassuka P; Koffi S; Géraldo A; Atakouma Y
    Tunis Med; 2007 Sep; 85(9):798-800. PubMed ID: 18254314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies in children with type 2 diabetes mellitus.
    Umpaichitra V; Banerji MA; Castells S
    J Pediatr Endocrinol Metab; 2002 Apr; 15 Suppl 1():525-30. PubMed ID: 12017227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is type 2 diabetes a chronic inflammatory/autoimmune disease?
    Syed MA; Barinas-Mitchell E; Pietropaolo SL; Zhang YJ; Henderson TS; Kelley DE; Korytkowski MT; Donahue RP; Tracy RP; Trucco M; Kuller LH; Pietropaolo M
    Diabetes Nutr Metab; 2002 Apr; 15(2):68-83. PubMed ID: 12059095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical heterogeneity of childhood diabetes in Baranya county].
    Makovi H; Soltész G; Hermann R
    Orv Hetil; 2002 Nov; 143(44):2489-92. PubMed ID: 12674804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dyslipidemia in children with type 2 diabetes vs. obesity.
    Newfield RS; Dewan AK; Jain S
    Pediatr Diabetes; 2008 Apr; 9(2):115-21. PubMed ID: 18221437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The serum levels of proinsulin and their relationship with IGFBP-1 in obese children.
    Kamoda T; Saitoh H; Inudoh M; Miyazaki K; Matsui A
    Diabetes Obes Metab; 2006 Mar; 8(2):192-6. PubMed ID: 16448523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary C-peptide creatinine ratio to differentiate type 2 diabetes mellitus from type 1 in pediatric patients.
    Elzahar W; Arafa A; Youssef A; Erfan A; El Amrousy D
    Eur J Pediatr; 2020 Jul; 179(7):1115-1120. PubMed ID: 32052124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome.
    Heald AH; Kaushal K; Siddals KW; Rudenski AS; Anderson SG; Gibson JM
    Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):371-6. PubMed ID: 16915540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.